Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

NCT00817284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: bevacizumab and Irinotecan and radiotherapy
DRUG: Bevacizumab and Temozolomide and radiotherapy

Sponsor

Ulrik Lassen